Increased susceptibility of mice infected with Schistosoma mansoni to recombinant vaccinia virus: Association of viral persistence with egg granuloma formation

Authors

  • Jeffrey K. Actor,

    1. Laboratory of Parasitic Disease, National Institutes of Health, Bethesda
    Current affiliation:
    1. CytRx Corporation, 154 Technology Parkway, Technology Park/Atlanta, Norcross, GA 30092, USA
    Search for more papers by this author
  • Margaret A. Marshall,

    1. NIAID, and Metabolism Branch, NCI, National Institutes of Health, Bethesda
    Search for more papers by this author
  • Isam A. Eltoum,

    1. Laboratory of Parasitic Disease, National Institutes of Health, Bethesda
    Current affiliation:
    1. Department of Pathology, George Washington University Medical Center, Washington, DC 20037, USA
    Search for more papers by this author
  • R. Mark L. Buller,

    1. Laboratory of Viral Diseases, National Institutes of Health, Bethesda
    Current affiliation:
    1. Department of Molecular Microbiology and Immunology, St. Louis University School of Medicine, St. Louis, MO 63104, USA
    Search for more papers by this author
  • Jay A. Berzofsky,

    1. NIAID, and Metabolism Branch, NCI, National Institutes of Health, Bethesda
    Search for more papers by this author
  • Alan Sher

    Corresponding author
    1. Laboratory of Parasitic Disease, National Institutes of Health, Bethesda
    • Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, 9000 Rockville Pike, Building 4, Room 126, Bethesda, MD 20892, USA
    Search for more papers by this author

Abstract

BALB/c mice infected 7 weeks previously with Schistosoma mansoni and challenged with a recombinant vaccinia virus vPE16 expressing the human immunodeficiency virus envelope protein gp160 show a marked delay in hepatic viral clearance as compared to mice infected with vPE16 alone. This increase in viral persistence is accompanied by reduced gp120-specific Th1-associated cytokine responses as well as by impaired cytotoxic T lymphocyte (CTL) activity against targets expressing epitopes of the same antigen. To investigate the contribution of these defects to the observed delay in clearance of recombinant vaccinia virus, animals were challenged with vPE16 at different times following S. mansoni infection, and virus titers in tissues and viral-specific immune responses were measured simultaneously in the same animals. While normal resolution of virus occurred in schistosome-infected mice prior to parasite egg deposition, persistence within the liver was observed in animals challenged during the onset and peak phase of granuloma formation (6 to 8 weeks after S. mansoni infection). At later times, when schistosomiasis is in its chronic phase, normal viral clearance returned. This time course of viral resolution correlated in part with the observed pattern of decreased Th1 cytokine production toward viral antigens but was clearly less temporally related to the defect in virus-specific CTL activity. Immunohistochemical staining of liver sections from vaccinia/S. mansoni co-infected mice with polyclonal anti-vaccinia antibodies revealed that viral epitopes are localized primarily within granulomas. These experiments suggest that egg granulomas, by providing a microenvironment for viral expansion, in combination with the cytokine imbalance present during schistosome infection, can promote the expansion of vaccinia virus and possibly other viral agents.

Ancillary